Impact of GDMT in Uncontrolled Asthma Patients Receiving MHD Inhaled Corticosteroids + Long-acting β2 Agonist
NCT07718724
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
540
Enrollment
INDUSTRY
Sponsor class
Conditions
Uncontrolled Asthma
Interventions
BEHAVIORAL:
Intervention group
Sponsor
AstraZeneca